Jason Kralic

Jason Kralic Email and Phone Number

Co-founder & CEO, Tellus Therapeutics @ Tellus Therapeutics, Inc
Jason Kralic's Location
Raleigh-Durham-Chapel Hill Area, United States, United States
Jason Kralic's Contact Details
About Jason Kralic

Jason Kralic, Ph.D. is a neuropharmacologist and BD professional with broad experience in technology innovation, R&D, licensing and company creation. Jason co-founded Tellus Therapeutics with Duke neonatologist and stem cell biologist, Eric Benner, MD/PhD, focused on the development of treatments for neonatal brain injury. Jason founded Innervate BD Solutions in 2015, an advisory firm helping clients realize the full potential of their science and business through planning and execution of objective-driven strategies.Jason was previously Associate Vice President of Technology Innovation at Wake Forest Baptist Medical Center where he facilitated the evaluation, protection, development and licensing of therapeutics, medical devices, diagnostics and digital health technologies aimed at improving human health. Prior to Wake Forest Innovations, Jason was Vice President of Business Development at Opexa Therapeutics and Head of Business Development for Neurosciences R&D at GlaxoSmithKline responsible for setting the BD strategy, leading licensing and M&A activities and facilitating relationships with alliance partners. Jason has also served in scientific licensing roles at UCB Pharma and Schwarz Biosciences. Jason holds a Ph.D. in pharmacology from the University of North Carolina at Chapel Hill and completed post-doctoral training at the University of Zurich. Throughout his career, Jason has been a strong advocate for STEM education and growth of biotechnology in North Carolina.

Jason Kralic's Current Company Details
Tellus Therapeutics, Inc

Tellus Therapeutics, Inc

View
Co-founder & CEO, Tellus Therapeutics
Jason Kralic Work Experience Details
  • Tellus Therapeutics, Inc
    Co-Founder And Ceo
    Tellus Therapeutics, Inc Oct 2018 - Present
    Durham, Nc, Us
    Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus' lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in an animal model of perinatal brain injury and multiple sclerosis and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.
  • Diviner
    Advisor
    Diviner Sep 2020 - Present
    Indianapolis, In, Us
    Collective Intelligence to help investors and biopharma companies make better drug development decisions.
  • Innervate Bd Solutions, Llc
    Founder And Principal Advisor
    Innervate Bd Solutions, Llc Feb 2015 - Present
    Innervate provides business development services to individuals, non-profit institutions and both large and small companies and specializes in technology platforms, medicines development programs and patient advocacy across neurology, psychiatry and pain.
  • Bioscience Pharma Partners, Llc
    Director Of Business Development
    Bioscience Pharma Partners, Llc Sep 2018 - Jan 2022
    BPP is focused on treatment of neuroinflammation and pursuing clinical development of BPP-1001 in patients with chronic neuroinflammation and neurodegenerative disorders.
  • Duke University Health System
    Research Associate
    Duke University Health System Oct 2018 - Oct 2020
    Durham, North Carolina, Us
  • Wake Forest Innovations
    Associate Vice President Of Technology Innovation
    Wake Forest Innovations May 2016 - Apr 2018
    Winston-Salem, Nc, Us
    At the Center for Technology Innovation & Commercialization, Jason leads efforts to engage with Wake Forest Baptist Medical Center investigators, clinicians, faculty and staff and with industry to support the ideation and development of ideas and discoveries to the point where they can be commercialized with industry through the work of the licensing team at Wake Forest Innovations.
  • Opexa Therapeutics
    Vice President Of Business Development
    Opexa Therapeutics Jun 2015 - May 2016
    The Woodlands, Texas, Us
  • Glaxosmithkline
    Head, Neurosciences Business Development
    Glaxosmithkline Aug 2012 - Feb 2015
    Brentford, Middlesex, Gb
    • Accountable for Neurosciences R&D business development globally including in-licensing and divestiture activity• Lead deal teams responsible for triaging, due diligence, business case generation and presentation to scientific and investment boards• Responsible for therapeutic area BD strategy to support R&D business cycle and commercial franchise objectives• Work autonomously to support internal customers (Therapeutic Area Head and Franchise Head) and effectively with teams in a global organization (US, UK and China)• Cultivate relationships with potential partners and thought leaders, promote GSK by serving as speaker/panelist at conferences and maintain strong knowledge of industry landscape
  • Glaxosmithkline
    Director, Scientific Licensing
    Glaxosmithkline Feb 2009 - Aug 2012
    Brentford, Middlesex, Gb
    • Ensure the delivery of high quality scientific evaluation and prioritization of potential licensing/M&A opportunities in line with the R&D strategic plan• Responsible for identification and triage of R&D and commercial partnering opportunities in areas of Psychiatry, Neurology and Pain• Lead due diligence teams overseeing technical evaluation of asset including CMC, Non-clinical, Clinical, Regulatory, Legal/IP, Quality Assurance and Commercial aspects• Prepare and present licensing recommendations for decision at Scientific Advisory, Global Safety and Project Investment Boards and Corporate Executive Team• Develop and implement BD strategy for the Neurosciences therapeutic area• Support valuation and contract negotiation• Lead out-licensing, divestment and creation of spin-out of GSK development programs and intellectual property
  • Ucb Pharma
    Associate Director, R&D Partnering And Business Development - Cns
    Ucb Pharma Oct 2007 - Feb 2009
    Brussels, Be
    • Managed licensing evaluations entailing establishing company contact, delivering corporate presentation, conducting technical evaluation, establishing and leading internal evaluation teams, presenting project proposal to senior management, conducting due diligence, generating management report for Executive Board and assisting in valuation and contract negotiation• Conducted competitive pipeline and gap analyses for neurological, psychiatric and autoimmune disease licensing strategies • Led cross-functional team responsible for identifying and evaluating generic reformulations for the treatment of pain• Implemented Competitive Intelligence and Licensing database (Vertical*i/Inova) to increase efficiency of business development organization
  • Schwarz Pharma
    Manager, Corporate Business Development And Licensing
    Schwarz Pharma Sep 2005 - Sep 2007
    Us
  • University Of Zurich
    Postdoctoral Scientist
    University Of Zurich Jul 2003 - Aug 2005
    Zurich, Ch
    • Managed two core projects (“neurogenesis and epilepsy” and “adaptations in inhibitory synaptic circuits”) • Supervised a Master’s program student and her research project • Presented research findings at international meetings and published in peer-reviewed journals• Created and presented curriculum at public schools for Brain Awareness Week as a member of the Neuroscientist/Teacher Partner Program • Served as a peer reviewer for European Journal of Neuroscience

Jason Kralic Skills

Biotechnology Pharmaceutical Industry Life Sciences Neuroscience Pharmacology Drug Development Drug Discovery Clinical Development Business Development Biopharmaceuticals Clinical Trials R&d Strategy Commercialization Technology Transfer Oncology Cro Immunology Biomarkers Molecular Biology Lifesciences Regulatory Affairs Licensing Biochemistry Protein Chemistry In Vitro In Vivo Vaccines Infectious Diseases Assay Development Research And Development Medical Devices Cell Biology Regulatory Submissions Gmp Glp Chemistry Cell Translational Medicine Translational Research Drug Delivery Cro Management

Jason Kralic Education Details

  • University Of North Carolina At Chapel Hill School Of Medicine
    University Of North Carolina At Chapel Hill School Of Medicine
    Pharmacology/Neuroscience
  • Ohio Wesleyan University
    Ohio Wesleyan University
    Biochemistry

Frequently Asked Questions about Jason Kralic

What company does Jason Kralic work for?

Jason Kralic works for Tellus Therapeutics, Inc

What is Jason Kralic's role at the current company?

Jason Kralic's current role is Co-founder & CEO, Tellus Therapeutics.

What is Jason Kralic's email address?

Jason Kralic's email address is ja****@****gsk.com

What is Jason Kralic's direct phone number?

Jason Kralic's direct phone number is +191949*****

What schools did Jason Kralic attend?

Jason Kralic attended University Of North Carolina At Chapel Hill School Of Medicine, Ohio Wesleyan University.

What are some of Jason Kralic's interests?

Jason Kralic has interest in Social Services, Children, Education, Science And Technology, Human Rights, Health.

What skills is Jason Kralic known for?

Jason Kralic has skills like Biotechnology, Pharmaceutical Industry, Life Sciences, Neuroscience, Pharmacology, Drug Development, Drug Discovery, Clinical Development, Business Development, Biopharmaceuticals, Clinical Trials, R&d.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.